SHZ · 000423.SZ
Dong-E-E-Jiao Co.,Ltd.
CN¥47.93+CN¥0.60 (+1.27%)
Dong-E-E-Jiao Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.87% below the high.
Loading market information…
SHH · 600572.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang CONBA Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang CONBA Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.15 per share, paid annual. The forward yield is 3.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang CONBA Pharmaceutical Co.,Ltd.’s next earnings report is currently expected on Apr 16, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang CONBA Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang CONBA Pharmaceutical Co., Ltd., a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd., is headquartered in Hangzhou, China. Established in 1969, and formerly known as Lanxi Yunshan Pharmaceutical Factory until its name change in October 1999, the company specializes in the research, development, manufacturing, and distribution of traditional Chinese medicines and botanical products across China. Its broad portfolio extends to include chemical pharmaceuticals, proprietary Chinese medicines, vision care products, dietary supplements, general health supplies, everyday wellness goods, food items, and various personal care products.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 | Oct 29, 2024 | CN¥0.05 | CN¥1.46B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥47.93+CN¥0.60 (+1.27%)
Dong-E-E-Jiao Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.87% below the high.
CN¥18.80-CN¥0.10 (-0.53%)
Chengdu Kanghong Pharmaceutical Group Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.13% below the high.
CN¥5.55+CN¥0.26 (+4.91%)
Harbin Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.71% below the high.
CN¥72.44-CN¥0.61 (-0.84%)
Fujian Cosunter Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.38% below the high.
CN¥15.04+CN¥0.54 (+3.72%)
Guobang Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.77% below the high.
CN¥4.55+CN¥0.01 (+0.22%)
North China Pharmaceutical Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.06% below the high.
CN¥1.89CN¥0.00 (0.0%)
New Journey Health Technology Group Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
CN¥4.34+CN¥0.01 (+0.23%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.81% below the high.
